In this interview podcast, Dr. Jay Bhattacharya discusses new initiatives at the NIH, including a $50 million autism data science initiative, potential treatments using Leucovorin, and cautions regarding Tylenol use during pregnancy. The conversation explores the replication crisis in science, the need for bold funding models akin to Silicon Valley's approach to venture capital, and the importance of rebuilding public trust in science by emphasizing rigorous, reproducible research and transparent communication. Bhattacharya also addresses the allocation of NIH funds, the role of political input, and the need to focus on prevalent chronic diseases and improve life expectancy in the U.S. The discussion further covers strategies to support early career investigators, promote academic freedom, and integrate AI in healthcare while ensuring patient privacy and data security.
Sign in to continue reading, translating and more.
Continue
